AKT2 and breast cancer: In conclusion, our findings reveal both universal mortality markers, such as HERC2 and MAPK7, and age-specific divergences exemplified by AKT2, FOXO3, and RICTOR, emphasizing the importance of integrating clinical variables with transcriptomic signatures to refine risk stratification in Luminal A breast cancer across different age groups.